A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors
Clinical trial NCT02065063 · COMPLETED
Trial details
- NCT number
- NCT02065063
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-22
- Primary completion
- 2016-06-23
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.